Fasting Clinical Trial
Official title:
AbStats at the Bedside: Improving Patient Feeding Decisions Using an Abdominal Acoustic Score
This study is being conducted to determine whether providers who have access to their
patients' acoustic intestinal rate score as calculated by an abdominal acoustic sensor that
continuously monitors bowel sounds (AbStats) will be more likely to advance their patients'
diets to a solid diet sooner than those who do not have access to this rate. AbStats
calculates intestinal rates by using two small sensors placed on a patient's abdomen to
measure and analyze their abdominal sounds.
Patients will be asked to wear a sensor every morning for 20 minutes while they are fasting
daily during their inpatient visit. The sensor will measure the sounds within their abdomen.
This data will be interpreted by the AbStats device, which will provide an intestinal rate
measurement based on the sounds recorded by the sensors.
This intestinal rate will be provided to the patient's treating physician together with other
vital signs. The doctor, at his/her discretion, may choose to use this information to make
decisions about the patient's feeding status.
The research team will use an abdominal acoustic sensor that continuously monitors bowel
sounds (AbStats) to obtain acoustic measurements from 50 Cedars-Sinai Medical Center (CSMC)
hospital patients by placing a disposable sensor on their abdomen. The sensor will be
connected to a bedside monitor which records the sounds collected by the sensors and
interprets them to create an intestinal rate reading, measured as acoustic events per minute.
The research team will enter this score into the patient's chart and make it available to the
patient's clinician(s), to use at their discretion to make decisions on whether or not to
advance their patient's diet based on intestinal rate interpretation guidelines previously
developed. The entry will provide a numerical intestinal rate with a brief interpretation of
the score as listed below. This will be based on interpretations of the measures provided by
the AbStats bedside computer, which have been previously developed in a wider research
study.6 The scores will be interpreted using the following criteria:
Fasting intestinal rate score of <3 per minute: Ileus; Consider holding diet advancement
until there is more evidence of GI function (feeding "red light")
Fasting intestinal rate score of 3-5 per minute: Slow motility; Consider advancing to liquid
diet if NPO, assuming it is otherwise medically and surgically appropriate (feeding "yellow
light")
Fasting intestinal rate score of >5 per minute: Normal motility; consider advancing to full
diet if medically and surgically appropriate (feeding "green light")
Even though these readings will be provided in the patient chart, physicians must use their
clinical judgment and account for mental status, aspiration risk, medications, surgical and
medical comorbidities before making any feeding decisions. The intestinal rate is merely a
new piece of information that provides objective evidence of GI function; it is likely
superior to current best practices, which are notoriously unreliable for truly determining GI
functional status and motility.
The research team will discuss the project with the patient's medical teaching attending
physician, and will request their approval prior to approaching a patient. Once the doctor's
approval is secured, researchers will approach the patient and provide them with detailed
information about the project activities. If they agree to participate, the AbStats sensor
will be placed on the patient's abdomen every morning for 20 minutes while the patient is
fasting for the duration of their hospital stay. The sensor will be connected to a bedside
computer that will process the data and calculate an intestinal rate, which will appear on
the AbStats' gateway screen. The rate and its time-stamp will be entered into the patient's
CS-Link (CSMC's EHR) chart by the research team. Once the patient is discharged, their
participation in the study will be completed.
After discharge, the patient's chart will be reviewed by a member of the research staff.
Using the "Dietary Orders" section of the "Active Orders" tab of the "Patient Summary"
section of the patients CS-Link chart, we will determine the length of time from fasting
(NPO) to full diet for each patient, as X1-X0, where X1 is time of order to full diet and X0
is time of hospital admission as noted in the "Encounters" section of the patient chart. Full
diet will be determined from a dietary order in the chart stating "Diet Regular". The time to
full diet will be reported in hours.
Medical residents and members of the Cedars-Sinai Department of Health Services Research
staff will collect the following data (measures) at the patient's bedside:
Patient time (hours) to advancement to solid diet Abdominal intestinal rate measured by
AbStats disposable biosensor
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03754920 -
Prolonged Fasting With Meditation and Mild Physical Exercise
|
N/A | |
Completed |
NCT05272332 -
Gastric Ultrasound Prior to Extubation
|
||
Completed |
NCT04247464 -
Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients
|
N/A | |
Completed |
NCT01067001 -
Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study
|
N/A | |
Completed |
NCT00757094 -
Safety and Feasibility of Fasting While Receiving Chemotherapy
|
N/A | |
Completed |
NCT01506713 -
Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT04514380 -
Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
|
||
Completed |
NCT05756868 -
The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior
|
N/A | |
Completed |
NCT05134207 -
The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty
|
N/A | |
Completed |
NCT05031598 -
Long-term Fasting: Multi-system Adaptations in Humans
|
N/A | |
Recruiting |
NCT04501393 -
Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients
|
N/A | |
Enrolling by invitation |
NCT04027478 -
Can Fasting Decrease the Side Effects of Chemotherapy?
|
N/A | |
Completed |
NCT05219136 -
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
|
N/A | |
Recruiting |
NCT04625608 -
Effect of Premedicant Oral Paracetamol on Gastric Volume and pH
|
Phase 4 | |
Not yet recruiting |
NCT02562638 -
Pre-Procedural Fasting in Cardiac Intervention
|
N/A | |
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Completed |
NCT01949987 -
Does Oral Intake Decreases Postoperative Pain Score in Children
|
N/A | |
Completed |
NCT01721187 -
Satiety Effects on the Neural Valuation of Food
|
N/A | |
Completed |
NCT01713647 -
Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
|
Phase 1 | |
Completed |
NCT01831700 -
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
|
Phase 1 |